Actelion Pharmaceuticals Ltd
Summary
Actelion Pharmaceuticals Ltd is registered in Switzerland and entered in the “UID register” under number CHE-103.975.795. Its legal form is Société à responsabilité limitée (Sàrl) – private limited company (Switzerland). According to GLEIF, its ultimate parent is Johnson & Johnson (United States). That group has 209 subsidiaries with LEIs in 47 countries, 12 of them in Switzerland. The LEI was first issued on 20 Jun 2024 and the record was last updated on 15 Jul 2026; the next renewal is due by 20 Jul 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Société à responsabilité limitée (Sàrl) private limited company (Switzerland) |
|---|---|
| Register | UID register · Register website |
| Registration number | CHE-103.975.795 |
| Registration authority | Federal Statistical Office |
| Jurisdiction | Switzerland |
| Registered address | Gewerbestrasse 16, 4123 Allschwil, Switzerland |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 18 Dec 1997 |
| LEI | 254900Y3VARB8ADXN390 |
| LEI status | active |
| LEI first issued | 20 Jun 2024 |
| LEI record last updated | 15 Jul 2026 |
| Next LEI renewal | 20 Jul 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Ultimate parent | |
|---|---|
| Parent | Johnson & Johnson |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | other official documents |
| Corroboration | supplied by the entity only |
| Relationship start | 18 Dec 1998 |
| Recorded at GLEIF since | 20 Jun 2024 |
| Last updated | 29 Jul 2025 |
| Record status | current |
Parent not reported to GLEIF
- Direct parent: the parent has no LEI and has not consented to obtain one.
ISINs mapped to this LEI (1)
CH0009006070
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.